|
Copyright
©
2012
by the Forschungszentrum Jülich GmbH
|
Key Topics
- Setting the scenery: Assessing unclear risks
- Models of cancer development
- RF EMF cancer risk assessment: What do we know, what do
we
need to know?
- The framework for assessing RF EMF cancer risks
- From present to the future: The contribution of genotoxic
research to risk assessment
- Validity and reliability of genotoxic studies for cancer
risk assessment
- Chromosomal aberration analysis
- Risk assessment based on genetic data
- Visions of toxicity testing and risk assessment in the 21st
century
- Current and future prospects of omics for cancer risk
assessment
- Validity and reliability of current omics studies for
cancer risk assessment
- Future developments in omics technologies for cancer risk
assessment
- Omics contributions to critical issues in cancer risk
assessment
- For hazard screening, extrapolation and susceptibility
- Omics for dealing with unclear risks
- The RF-EMF case
- Implications for Policy Making - Omics and the
precautionary principle
|
|
«
|
May
2012
|
»
|
| Su |
Mo |
Tu |
We |
Th |
Fr |
Sa |
|
|
1 |
2 |
3 |
4 |
5 |
| 6 |
7 |
8 |
9 |
10 |
11 |
12 |
| 13 |
14 |
15 |
16 |
17 |
18 |
19 |
| 20 |
21 |
22 |
23 |
24 |
25 |
26 |
| 27 |
28 |
29 |
30 |
31 |
|
|
-








|